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compared to the planning CT: the CTV70 shrinkage (in cc) and 
the PG dose difference (p<0.01 and R²=0.71). 
 
 
Conclusions: Monitoring the PG volumes and the head and 
neck thickness during the course of treatment allows to 
identify PG overdose at the fraction. The first weekly CT can 
be used to predict PG overdose and therefore to target the 
patients for a dose-guided ART strategy. Other series of 
patients are needed to confirm our nomograms.  
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Purpose/Objective: Accurate target volume delineation is 
essential in the treatment of head and neck cancers using 
intensity-modulated radiotherapy (IMRT). To adapt to the 
increasing use of a volumetric outlining approach in this 
setting, contouring using a volumetric expansion method was 
incorporated with anatomical delineation into the protocols 
for De-ESCALaTE HPV, a multi-centre phase III trial for 
patients with oropharyngeal squamous cell carcinomas. 
As part of radiotherapy trials quality assurance, we evaluate 
the conformity of clinician outlining between these two 
approaches for target volume delineation. 
Materials and Methods: The first submissions of two pre-
accrual outlining benchmark cases (case 1: unilateral neck 
treatment; case 2: bilateral neck treatment) were analysed 
and compared against the trials management group (TMG) 
consensus contours for both delineation methods. The high 
dose clinical target volume (CTV) and prophylactic dose CTV 
were quantitatively assessed using Dice Similarity Coefficient 
(DSC) described by the formula:  
  
where A and B represent regions of interest. 
Results: Anatomical and volumetric outlining was assessed 
for 13 and 11 centres respectively. There was an overlap of 5 
centres which changed to using the volumetric approach 
after the protocol amendment. 
The mean DSC for delineation of high dose CTV was 
systemically greater for volumetric (case 1: 0.82, range 0.69 
– 0.96; case 2: 0.86, range 0.76 – 0.92) than anatomical (case 
1: 0.69, range 0.59 – 0.75; case 2: 0.71, range 0.60 – 0.77) 
outlining for both benchmark cases (case 1: p=0.021; case 2: 
p<0.001). 
There was no statistical difference in the mean DSC for 
prophylactic dose CTV delineation between the 2 outlining 
methods (case 1: p=0.601, case 2: p=0.735). In case 1 the 
mean DSC was 0.59 (range 0.41 – 0.70) and 0.64 (range 0.41 – 
0.82), in case 2 the mean DSC was 0.67 (range 0.61 – 0.75) 
and 0.68 (range 0.49 – 0.81) for volumetric and anatomical 
outlining respectively. 
There was greater concordance in high dose CTV delineation 
compared to prophylactic dose CTV for both benchmark cases 
using either of the two outlining methods. 
Conclusions: The volumetric approach to head and neck 
outlining appears to improve the consistency of high dose 
CTV delineation between centres and the trial consensus 
contours, suggesting that incorporating a geometric margin 
around the GTV, edited for air/bone, is likely to be less open 
to interpretation than anatomical outlining. Both delineation 
methods give rise to similar conformity for prophylactic dose 
CTV outlining, although there is more variation compared to 
high dose CTV. Adaptation of radiotherapy guidelines within 
the course of a trial can improve the concordance of clinician 
target volume definition. In addition, feedback to centres on 
pre-accrual benchmark cases and prospective/retrospective 
case reviews has been implemented to ensure trial protocol 
adherence.  
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